Literature DB >> 26686970

Clinical events and their relation to the tumor necrosis factor-alpha and interleukin-10 genotypes in Sickle-Cell-Anemia patients.

Jânio Emanuel Andrade Cavalcante1, Rosângela Pinheiro Gonçalves Machado2, Marilia Rocha Laurentino3, Talyta Ellen de Jesus dos Santos4, Izabel Cristina Justino Bandeira4, Pedro Aurio Maia Filho1, Monalisa Feliciano Figueiredo5, Alice Maria Costa Martins5, Romélia Pinheiro Gonçalves Lemes5.   

Abstract

OBJECTIVE/
BACKGROUND: Sickle-cell anemia (SCA) is a genetic blood disease characterized by chronic inflammation and a heterogeneous clinical picture. Serum tumor necrosis factor (TNF-alpha) and interleukin 10 (IL-10) levels are associated with the clinical course of SCA. This study aimed to evaluate the association between the frequency of the polymorphisms TNF-alpha-308 G→A, IL-10-1082 G→A, IL-10-819 C→T, and IL-10-592 A→C; serum TNF-alpha; and IL-10 levels, and the incidence of clinical events in SCA patients.
METHODS: Polymerase chain reaction-restriction fragment length polymorphism and enzyme-linked immunosorbent assay were performed on 25 adults with SCA at the steady state; their data were compared with those for 26 healthy individuals.
RESULTS: The most frequent genotype of the TNF-alpha polymorphism was GG (low producer), and the most frequent genotype of the IL-10 polymorphisms was "low producer" (ACC ACC, ACC ATA, ATA ATA). The TNF-alpha levels were significantly higher in SCA in patients with acute chest syndrome (ACS). The IL-10 levels were reduced in polytransfusion and in patients with ACS.
CONCLUSION: The patients presented prevalence of TNF-alpha and IL-10 low-profile producer. The cytokine serum levels presented an association with the presence of polytransfusion and ACS in SCA patients.
Copyright © 2015 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anemia; Cytokines; Genetic; Polymorphism; Sickle cell

Mesh:

Substances:

Year:  2015        PMID: 26686970     DOI: 10.1016/j.hemonc.2015.11.002

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  6 in total

Review 1.  Anti-inflammatory cytokines in sickle cell disease.

Authors:  Adekunle E Alagbe; Igor F Domingos; Adekunle D Adekile; Maria H S L Blotta; Magnun N N Santos
Journal:  Mol Biol Rep       Date:  2022-01-09       Impact factor: 2.316

2.  High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.

Authors:  Igor F Domingos; Diego A Pereira-Martins; Marcondes J V C Sobreira; Romulo T D Oliveira; Adekunle E Alagbe; Carolina Lanaro; Dulcineia M Albuquerque; Maria H S L Blotta; Aderson S Araujo; Fernando F Costa; Antonio R Lucena-Araujo; Maria F Sonati; Marcos A C Bezerra; Magnun N N Santos
Journal:  Ann Hematol       Date:  2020-03-05       Impact factor: 3.673

3.  The Inflammatory Response to Surgery in Sickle Cell Disease Patients Undergoing Cholecystectomy.

Authors:  Adewale O Adisa; Tewogbade A Adedeji; Rahman A Bolarinwa; Temilola O Owojuyigbe; Olusola A Jeje; James Glasbey; Norah O Akinola
Journal:  JSLS       Date:  2019 Apr-Jun       Impact factor: 2.172

4.  Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients.

Authors:  Alexander Leonardo Silva-Junior; Nadja Pinto Garcia; Evilázio Cunha Cardoso; Stephanny Dias; Andrea Monteiro Tarragô; Nelson Abrahim Fraiji; Matheus Souza Gomes; Laurence Rodrigues Amaral; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Erich Vinicius De Paula; Allyson Guimarães Costa; Adriana Malheiro
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

5.  Hemoglobin Genotypes Modulate Inflammatory Response to Plasmodium Infection.

Authors:  Keri Oxendine Harp; Felix Botchway; Yvonne Dei-Adomakoh; Michael D Wilson; Joshua L Hood; Andrew A Adjei; Jonathan K Stiles; Adel Driss
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

6.  Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis.

Authors:  Nadja Pinto Garcia; Alexander Leonardo S Júnior; Geyse Adriana S Soares; Thainá Cristina C Costa; Alicia Patrine C Dos Santos; Allyson Guimarães Costa; Andréa Monteiro Tarragô; Rejane Nina Martins; Flávia do Carmo Leão Pontes; Emerson Garcia de Almeida; Erich Vinícius de Paula; Olindo Assis Martins-Filho; Adriana Malheiro
Journal:  J Immunol Res       Date:  2020-01-08       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.